26934-56-5

Upstream product

• 23521-81-5 (1,4-dioxaspiro[4.5]dec-8-yl)methanol 
• 133-59-5 Toluene-2-sulfonyl chloride 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 17159-83-0 4-<<(p-tolylsulfonyl)oxy>methyl>cyclohexanone 
• 17159-87-4 bicyclo<3.1.1>heptan-2-one 
• 73991-28-3 2-formyl-2-phenylselenylbicyclo<3.1.1>heptane 
• 286-34-0 bicyclo[3.1.1]heptane 
• 17159-84-1 4-(methoxymethyl)cyclohexan-1-one 
• 17159-86-3 4-(ethoxymethyl)cyclohexanone 
• 1078729-43-7 8-(4-ethoxy-2,3-difluorophenoxymethyl)-1,4-dioxaspiro[4.5]decane 
• 1097629-90-7 4-(3,3,3-trifluoropropylsulfonylmethyl)cyclohexanone 
• 1097629-93-0 1-fluoro-4-(3,3,3-trifluoropropylsulfonylmethyl)cyclohexanone 
• 1097629-92-9 1,1-difluoro-4-(3,3,3-trifluoropropylsulfonylmethyl)cyclohexanone 
• 1097629-94-1 1-ethynyl-4-(3,3,3-trifluoropropylsulfonylmethyl)cyclohexanol 
• 1097629-95-2 1-ethynyl-1-fluoro-4-(3,3,3-trifluoropropylsulfonylmethyl)cyclohexane 
• 1097630-12-0 4-(3,3,3-trifluoropropylsulfonylmethyl)-cyclohexanone O-methyloxime 
• 1097630-13-1 1-ethynyl-4-(3,3,3-trifluoropropyl-1-sulfonylmethyl)cyclohexene 

Relevant academic research and scientific papers

MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE

The present disclosure provides for compounds of formula (I), wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of formula (I).

LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE

A liquid crystal compound is provided that has excellent characteristics, such as a negatively large dielectric anisotropy. A liquid crystal composition containing the compound, and a liquid crystal display device containing the composition are also provi

ANIMAL ECTOPARASITE CONTROL COMPOSITION

The present invention provides an animal ectoparasite control composition containing an insecticidal component and an adipate, and a method of controlling an animal ectoparasite which comprises administering an effective amount of the animal ectoparasite control composition to an animal.

LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE

A liquid crystal compound is provided that has excellent characteristics, such as a negatively large dielectric anisotropy. A liquid crystal composition containing the compound, and a liquid crystal display device containing the composition are also provi

HALOGEN-CONTAINING ORGANOSULFUR COMPOUND AND USE THEREOF

There is provided a halogen-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein, m represents 0, 1 or 2, n represents 0, 1 or 2, A represents optionally substituted C3-C7 cyclo

NITRILE COMPOUND AND ITS USE FOR CONTROL OF ARTHROPOD PEST

There is provided a nitrile compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein m represents in integer of 0 to 4; n represents an integer of 1 to 4; q represents an integer of 0 to 4; Q represents a